Skip to content

Chemotherapy and Breast Cancer Spread: Key Facts to Understand

Cancer Spread in Breasts and Chemotherapy: Essential Information

Treatment of Breast Cancer Metastasis through Chemotherapy: A Comprehensive Overview
Treatment of Breast Cancer Metastasis through Chemotherapy: A Comprehensive Overview

Chemotherapy and Breast Cancer Spread: Key Facts to Understand

Metastatic breast cancer (MBC) can progress during chemotherapy, a challenging situation that arises when cancer cells become resistant or certain metastatic lesions grow despite treatment. This progression is often characterized by the appearance of new or growing tumors in existing or new sites, a condition sometimes referred to as oligoprogressive disease if it is limited to a few metastatic lesions (up to 5).

Signs of progression may include worsening symptoms related to the affected organs, such as pain, respiratory symptoms if the lungs are involved, or neurological deficits for brain metastases. Imaging or biomarker evidence of tumor growth despite ongoing chemotherapy further confirms the progression.

When progression occurs, treatment strategies need to be re-evaluated. Options may include continuing the current chemotherapy combined with local ablative therapies like stereotactic body radiation therapy (SBRT) or surgery for isolated progressing lesions, particularly in HER2+ MBC. However, robust prospective data are still lacking for this approach[1].

Another option is to switch systemic therapy if the cancer is broadly progressing, often moving to different chemotherapy agents, targeted therapies, or immunotherapy based on the tumor subtype and previous treatments[2][4]. For lung metastases or other organ-specific involvement, local treatments like surgery or radiation may be used if symptomatic or limited in number, but systemic treatment remains the mainstay due to the cancer’s widespread nature[2].

Novel agents and combination approaches, such as adding targeted drugs like anti-HER2 therapies for HER2+ MBC or aprepitant with chemotherapy in non-luminal cases, are under clinical evaluation or showing promise in extending progression-free survival and overall survival[1][3][5].

In summary, progression during chemotherapy indicates a need for re-evaluation of the treatment strategy, balancing systemic options and possible local treatments based on the extent and location of progression, tumor biology, and patient tolerance[1][2][4]. Monitoring for new symptoms and routine imaging are key to detecting progression early.

Chemotherapy is used to improve survival from breast cancers by stopping the cancer from growing and spreading. Regular follow-up visits and testing with an oncologist are crucial to determine if the chemotherapy is effective. It's important to note that if breast cancer tumors grow bigger during chemotherapy or spread to the rest of the body, it means the chemotherapy has been unsuccessful.

If metastatic breast cancer progresses, some people may choose to stop chemotherapy treatment when their cancer has reached an advanced stage. However, the best treatment option depends on various factors, including the location and extent of the cancer, the patient's overall health, and their personal preferences.

Metastatic breast cancer can spread to the brain, liver, lungs, and bones during its progression. Symptoms can vary depending on the affected organ. For instance, brain metastases can lead to headaches, dizziness, or seizures, while lung metastases may cause shortness of breath. Bone metastases can cause bone pain or fractures, and liver metastases might induce jaundice.

Doctors can perform blood tests and imaging tests to see if chemotherapy is working. If a fever of 100.5oF (38oC) or higher, cough and sore throat, chills, diarrhea, ear pain, rash, swelling or inflammation at the catheter site, cloudy or bloody urine, ear pain, headache, sinus pain, stiff or sore neck, or any other unusual symptoms occur during chemotherapy, medical advice should be sought immediately.

More information can be found about what happens if chemotherapy does not work, and the ongoing research into novel agents and combination approaches to extend progression-free survival and overall survival for those with metastatic breast cancer.

  1. Metastatic breast cancer (MBC) can progress during chemotherapy, a challenging situation that arises when cancer cells become resistant or certain metastatic lesions grow despite treatment.
  2. Signs of progression may include worsening symptoms related to the affected organs, new or growing tumors, imaging or biomarker evidence of tumor growth, and a condition sometimes referred to as oligoprogressive disease if it is limited to a few metastatic lesions (up to 5).
  3. When progression occurs, treatment strategies need to be re-evaluated, balancing systemic options and possible local treatments based on the extent and location of progression, tumor biology, and patient tolerance.
  4. Another option is to switch systemic therapy if the cancer is broadly progressing, often moving to different chemotherapy agents, targeted therapies, or immunotherapy based on the tumor subtype and previous treatments.
  5. Novel agents and combination approaches, such as adding targeted drugs or aprepitant with chemotherapy, are under clinical evaluation or showing promise in extending progression-free survival and overall survival for those with metastatic breast cancer.
  6. Doctors can perform blood tests and imaging tests to see if chemotherapy is working, and if a patient experiences fever, cough, sore throat, chills, diarrhea, ear pain, rash, swelling or inflammation at the catheter site, or any other unusual symptoms during chemotherapy, medical advice should be sought immediately.
  7. More information can be found about what happens if chemotherapy does not work, and the ongoing research into therapies and treatments for health and wellness for those with metastatic breast cancer, particularly in probing novel agents and combination approaches to extend progression-free survival and overall survival.

Read also:

    Latest